Skip to main content

Latest stock market podcasts

From the Helm: Clarity Pharmaceuticals Executive Chairman, Alan Taylor

Bell Direct
May 24, 2024

Embark on a journey of discovery with Dr. Alan as he unveils the cutting-edge breakthroughs of Clarity Pharma, a pioneering force in the relentless fight against cancer through next-generation radiopharmaceuticals. In this instalment of our From the helm series, Bell Direct’s Grady Wulff speaks to Clarity Pharmaceuticals (ASX:CU6) Executive Chairman, Dr Alan Taylor.

Clarity Pharmaceuticals specialises in the development of Targeted Copper Theragnostic for the imaging and treatment of selected cancers. Clarity Pharma has an extensive program of clinical development for imaging and cancer therapy with a series of important data readouts over the next few years.

In this video Dr. Alan discusses:

  • (1:27) an overview of the company, including their 7 clinical trials
  • (3:35) the promising results from their SECuRE trial
  • (11:55) why the radiopharmaceutical market is booming
  • (14:47) why Clarity Pharma could be an investment opportunity.

Weekly Wrap 21 June

Bell Direct
June 21, 2024

Morning Bell 20 June

Bell Direct
June 20, 2024

Morning Bell 18 June

Bell Direct
June 18, 2024

Morning Bell 17 June

Bell Direct
June 17, 2024

Weekly Wrap 14 June

Bell Direct
June 14, 2024

Morning Bell 13 June

Bell Direct
June 13, 2024

Morning Bell 12 June

Bell Direct
June 12, 2024

Morning Bell 11 June

Bell Direct
June 11, 2024

Weekly Wrap 7 June

Bell Direct
June 7, 2024

Morning Bell 6 June

Bell Direct
June 6, 2024

Morning Bell 5 June

Bell Direct
June 5, 2024

Morning Bell 4 June

Bell Direct
June 4, 2024